ERF — Eurofins Scientific SE Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Eurofins Scientific SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,718	6,712	6,515	6,951	7,296
Cost of Revenue
Gross Profit	1,902	1,513	1,364	1,552	1,561
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	5,245	5,675	5,673	5,934	6,512
Operating Profit	1,473	1,037	842	1,017	784
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,369	904	736	884	654
Provision for Income Taxes
Net Income After Taxes	1,043	683	568	687	473
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	783	610	310	406	475
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	749	581	257	353	475
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.03	3.51	2.91	3.5	2.72
Dividends per Share